Abstract:Background: Bronchodilators, which are compounds that can relax airway smooth muscle, are perhaps the most important component of combination therapy for chronic obstructive pulmonary disease, one of the most common non-communicable diseases in the world, which is the second most lethal disease after cardiovascular disease. Unfortunately, current clinical bronchodilators, whose activity is mediated by their interaction with muscarinic acetylcholine receptors, have side effects (up to myocardial infarction) due to their cross-affinity for different types of these receptors, including those prevalent in the heart muscle. Objectives: The aim of this work is to search/develop compounds — effective bronchodilators capable of selectively inhibiting type 3 muscarinic acetylcholine receptors (M3 receptors), predominantly present in smooth muscles and not characteristic of cardiomyocytes. Materials and Methods: High-throughput virtual screening of a collection of 150,000 compounds was conducted on the spatial structure of the M3 receptor, reconstructed in our previous studies. The effect of substances on contractile activity was investigated using tensometry in isometric mode on multicellular tracheal preparations. Antagonistic activity and type of inhibition were determined against the background of acetylcholine application (concentration range 10-10–10-3 M). To establish the affinity value of the compound-antagonist, the Schild regression equation was used. Results: Based on virtual screening data, a series of compounds — amides of 1-oxo-3-phenyl-iso-chroman-6-carboxylic acid — were selected for biological testing. For two of these compounds (Compounds 1 and 7), the ability to selectively inhibit M3 receptors was demonstrated. Specifically, the affinity value pKB for Compound 1 was 7.28 ± 0.70, with an IC50 of 5.25·10-8 M. A critically important advantage of this compound is its ability, at equal concentrations, to more effectively inhibit signal transmission through M3 receptors compared to ipratropium bromide — a clinical cholinergic receptor inhibitor. Conclusions: The sufficient effectiveness of inhibition and significantly increased selectivity of the studied compounds specifically towards M3 receptors provide strong grounds to consider these compounds as promising precursors of new generation cholinolytic drugs with targeted action on M3-type cholinergic receptors.

Role of M2 Receptor on the Muscarinic Functional Antagonism in the Human Isolated Bronchus

Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation

Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone

Muscarinic Inhibition of Nicotinic Transmission in Rat Sympathetic Neurons and Adrenal Chromaffin Cells

Involvement of Muscarinic M3 Receptor in the Development of M2 Macrophages in Allergic Inflammation

Smart agent based prepaid wireless energy meter

Binding modes and pharmacophoric features of muscarinic antagonism and β2 agonism (MABA) conjugates

Effect of SR-140333,a Neurokinin-1 Receptor Antagonist,on Airway Reactivity to Methacholine in Sedated Rats

Effect of Long‐Term Treatment with Massive Doses of 1α‐Hydroxyvitamin D3 on Calcium‐Phosphate Balance in Patients with Vitamin D‐Dependent Rickets Type II

Menthol inhibiting parasympathetic function of tracheal smooth muscle

Functional role of muscarinic receptor subtypes in calcium sensitization and their contribution to rho-kinase and protein kinase C pathways in contraction of human detrusor smooth muscle

Pleiotropic Effects of Bitter Taste Receptors on [Ca2+]i Mobilization, Hyperpolarization, and Relaxation of Human Airway Smooth Muscle Cells

New promising agents against COPD and asthma among the amides of 1-oxo-3-phenyl-isochroman-6-carboxylic acid

Calcium-Sensing Receptor Negative Allosteric Modulators Oppose Contraction of Mouse Airways

Extracellular acidification attenuates bronchial contraction via an autocrine activation of EP 2 receptor: its diminishment in murine experimental asthma

Effects of diazepam on mitosis and basal body duplication of synchronously dividing flagellate cells

Airway smooth muscle tone curbs hyperresponsiveness in experimental asthma

Airborne Fine Particulate Matter Causes Murine Bronchial Hyperreactivity Via Mapk Pathway-Mediated M-3 Muscarinic Receptor Upregulation

Partial Averaging and Resonance Trapping in a Restricted Three-Body System

M3 muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice

Pharmacological discrimination between muscarinic receptor signal transduction cascades with bethanechol chloride